Screener
Charles River Laboratories CRL Treasury stock, value, acquired
Treasury stock, value, acquired at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:TreasuryStockValueAcquiredCostMethod.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | Redeemable Noncontrolling Interests | Common Stock / Shares | Common Stock / Amount | Additional Paid-In Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Treasury Stock / Shares | Treasury Stock / Amount | Total Charles River Laboratories, Inc. Equity | Noncontrolling Interest | Total Equity |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividends declared to noncontrolling interests | (606) | — | — | — | — | — | — | — | — | — | — |
| Adjustment of redeemable noncontrolling interest to redemption value | 1,610 | — | — | (1,610) | — | — | — | — | (1,610) | — | (1,610) |
| Issuance of stock under employee compensation plans | — | 208 | 3 | 496 | — | — | — | — | 499 | — | 499 |
| Purchase of treasury shares | — | — | — | — | — | — | 647 | (112,437) | (112,437) | — | (112,437) |
| Share repurchase excise tax | — | — | — | — | — | — | — | (762) | (762) | — | (762) |
| Stock-based compensation | — | — | — | 19,781 | — | — | — | — | 19,781 | — | 19,781 |
| June 27, 2026 | 42,537 | 49,550 | 496 | 1,986,023 | 1,372,295 | (195,989) | 1,822 | (323,189) | 2,839,636 | 6,354 | 2,845,990 |
| See Notes to Unaudited Condensed Consolidated Financial Statements. |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's treasury stock, value, acquired?
- Charles River Laboratories (CRL) reported treasury stock, value, acquired of $112.44M in Q2 2026.
- How has Charles River Laboratories's treasury stock, value, acquired changed year-over-year?
- Charles River Laboratories's treasury stock, value, acquired increased by 1556.7% year-over-year, from $6.79M to $112.44M.
- What is the long-term trend for Charles River Laboratories's treasury stock, value, acquired?
- Over 2 years (2023 to 2025), Charles River Laboratories's treasury stock, value, acquired has grown at a 286.1% compound annual growth rate (CAGR), from $24.16M to $360.11M.
- What does treasury stock, value, acquired mean?
- The total cost incurred by the company to repurchase its own shares from the open market, recorded at the price paid.
Ask your AI about Charles River Laboratories's treasury stock, value, acquired.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude